Can gut bacteria predict celiac disease? new study follows At-Risk infants

NCT ID NCT02061306

Recruiting now Knowledge-focused Sponsor: Massachusetts General Hospital Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study follows 500 infants who have a close family member with celiac disease. Researchers track their genes, diet, gut bacteria, and other factors from birth to see what leads to the disease. The goal is to find ways to predict or prevent celiac disease in children who are at high risk.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this study could help identify early warning signs or risk factors for celiac disease, potentially leading to ways to prevent or detect it earlier in high-risk children.
What could go wrong: This is an observational study, not a treatment trial. It will not directly test any therapy, and results may take years to translate into practical advice or interventions.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CELIAC DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

celiac disease prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CELIAC DISEASE

Contacts and locations

Locations

MassGeneral Hospital for Children
RECRUITING

Boston, Massachusetts, 02114, United States
University of Roma La Sapienza
RECRUITING

Rome, 00185, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.